Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA

Watchlist Manager
Kiniksa Pharmaceuticals Ltd Logo
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Watchlist
Price: 22.15 USD -2.08% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Kiniksa Pharmaceuticals Ltd?
Write Note

Kiniksa Pharmaceuticals Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kiniksa Pharmaceuticals Ltd
Research & Development Peer Comparison

Comparables:

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Research & Development
-$96.5m
CAGR 3-Years
4%
CAGR 5-Years
8%
CAGR 10-Years
N/A

See Also

What is Kiniksa Pharmaceuticals Ltd's Research & Development?
Research & Development
-96.5m USD

Based on the financial report for Sep 30, 2024, Kiniksa Pharmaceuticals Ltd's Research & Development amounts to -96.5m USD.

What is Kiniksa Pharmaceuticals Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
8%

Over the last year, the Research & Development growth was -37%. The average annual Research & Development growth rates for Kiniksa Pharmaceuticals Ltd have been 4% over the past three years , 8% over the past five years .

Back to Top